Trial Profile

INTRAPERITONEAL AEROSOLISATION OF ALBUMIN-STABILIZED PACLITAXEL NANOPARTICLES FOR RECURRENT GI AND OVARIAN CANCER PHASE I/II STUDY PROTOCOL

Status: Recruiting

Phase of Trial: Phase I/II

Latest Information Update: 05 Apr 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paclitaxel (Primary) ; Paclitaxel (Primary)
Indications Carcinoma; Gastrointestinal cancer; Ovarian cancer; Pancreatic cancer
Focus Adverse reactions; Therapeutic Use

Most Recent Events

05 Apr 2021 This trial has been completed in Belgium (Global End Date: 29 Nov 2020), according to European Clinical Trials Database record.
07 Sep 2020 This trial has been completed in Denmark as per European Clinical Trials Database record
21 Dec 2018 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com